NATIONAL BANK OF CANADA /FI/ - BRIACELL THERAPEUTICS CORP ownership

Back to all holdings Add to watchlist

BRIACELL THERAPEUTICS CORP's ticker is and the CUSIP is 10778Y952. A total of 3 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Links
Filings
Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$100,000
-2.9%
1780.0%0.00%–
Q2 2022$103,000
-93.9%
178
-89.3%
0.00%
-100.0%
Q1 2022$1,686,000
-16.5%
1,663
-31.8%
0.01%
-28.6%
Q4 2021$2,020,000–2,440–0.01%–
 Download
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 3,815$1,667,1551.46%
SIMPLEX TRADING, LLC 1,800$70.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders